Effects of glucose or fat calories in total parenteral nutrition on fat metabolism and systemic inflammation in rats. 2011

Pei-Ra Ling, and Charlotte Andersson, and Robert Strijbosch, and Sang Lee, and Anthony Silvestri, and Kathleen M Gura, and Mark Puder, and Bruce R Bistrian
Laboratory of Nutrition/Infection, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.

This study compared the effects of total parenteral nutrition (TPN) by central vein with or without fat provided at maintenance energy requirement on fatty acid metabolism, de novo lipogenesis, and the risk of hepatic and systemic inflammation in rats. Study 1 was conducted in 2 groups: high glucose (HG), where fat-free TPN was given at maintenance levels of 180 kcal/(kg d), and low glucose (LG), where fat-free TPN containing 30% fewer calories at 126 kcal/(kg d) was provided by reducing 54 kcal/(kg d) from parenteral glucose. Study 2 contained 3 TPN groups: 1 LG group at 126 kcal/(kg d) and 2 groups at 180 kcal/(kg d) with 30% of total calories (54 kcal/[kg d]) either from soybean or fish oil emulsion. In both studies, animals fed a chow diet ad libitum were included. Plasma and hepatic triglyceride and phospholipid fatty acid profiles, enzymes indicating hepatic injury, and C-reactive protein levels (CRP) reflecting systemic injury were measured. In study 1, evidence of de novo lipogenesis was noted in LG and was more prominent in HG with elevation of CRP in HG. In study 2, de novo lipogenesis was reduced by adding either fat to LG to achieve maintenance energy levels. Moreover, adding fat as soybean oil but not fish oil significantly increased plasma and hepatic triglyceride and also elevated aspartate aminotransferase and CRP levels, reflecting inflammation. Thus, in rats, either hypocaloric feeding as glucose-based TPN or TPN provided at maintenance energy levels with the addition of fish oil limits hepatic lipid accumulation and prevents the evidence of hepatic and systemic injury found with maintenance level TPN as glucose only or glucose plus soybean oil.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D010289 Parenteral Nutrition, Total The delivery of nutrients for assimilation and utilization by a patient whose sole source of nutrients is via solutions administered intravenously, subcutaneously, or by some other non-alimentary route. The basic components of TPN solutions are protein hydrolysates or free amino acid mixtures, monosaccharides, and electrolytes. Components are selected for their ability to reverse catabolism, promote anabolism, and build structural proteins. Hyperalimentation, Parenteral,Intravenous Hyperalimentation,Nutrition, Total Parenteral,Parenteral Hyperalimentation,Total Parenteral Nutrition,Hyperalimentation, Intravenous
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D004041 Dietary Fats Fats present in food, especially in animal products such as meat, meat products, butter, ghee. They are present in lower amounts in nuts, seeds, and avocados. Fats, Dietary,Dietary Fat,Fat, Dietary
D005227 Fatty Acids Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed) Aliphatic Acid,Esterified Fatty Acid,Fatty Acid,Fatty Acids, Esterified,Fatty Acids, Saturated,Saturated Fatty Acid,Aliphatic Acids,Acid, Aliphatic,Acid, Esterified Fatty,Acid, Saturated Fatty,Esterified Fatty Acids,Fatty Acid, Esterified,Fatty Acid, Saturated,Saturated Fatty Acids
D005395 Fish Oils Oils high in unsaturated fats extracted from the bodies of fish or fish parts, especially the LIVER. Those from the liver are usually high in VITAMIN A. The oils are used as DIETARY SUPPLEMENTS. They are also used in soaps and detergents and as protective coatings. Fish Liver Oils,Fish Oil,Liver Oils, Fish,Oil, Fish,Oils, Fish,Oils, Fish Liver
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose

Related Publications

Pei-Ra Ling, and Charlotte Andersson, and Robert Strijbosch, and Sang Lee, and Anthony Silvestri, and Kathleen M Gura, and Mark Puder, and Bruce R Bistrian
April 1996, Drug metabolism and disposition: the biological fate of chemicals,
Pei-Ra Ling, and Charlotte Andersson, and Robert Strijbosch, and Sang Lee, and Anthony Silvestri, and Kathleen M Gura, and Mark Puder, and Bruce R Bistrian
January 1994, JPEN. Journal of parenteral and enteral nutrition,
Pei-Ra Ling, and Charlotte Andersson, and Robert Strijbosch, and Sang Lee, and Anthony Silvestri, and Kathleen M Gura, and Mark Puder, and Bruce R Bistrian
January 1984, JPEN. Journal of parenteral and enteral nutrition,
Pei-Ra Ling, and Charlotte Andersson, and Robert Strijbosch, and Sang Lee, and Anthony Silvestri, and Kathleen M Gura, and Mark Puder, and Bruce R Bistrian
March 1982, Clinical nutrition (Edinburgh, Scotland),
Pei-Ra Ling, and Charlotte Andersson, and Robert Strijbosch, and Sang Lee, and Anthony Silvestri, and Kathleen M Gura, and Mark Puder, and Bruce R Bistrian
January 1982, JPEN. Journal of parenteral and enteral nutrition,
Pei-Ra Ling, and Charlotte Andersson, and Robert Strijbosch, and Sang Lee, and Anthony Silvestri, and Kathleen M Gura, and Mark Puder, and Bruce R Bistrian
January 1981, The Journal of nutrition,
Pei-Ra Ling, and Charlotte Andersson, and Robert Strijbosch, and Sang Lee, and Anthony Silvestri, and Kathleen M Gura, and Mark Puder, and Bruce R Bistrian
October 1991, Clinical nutrition (Edinburgh, Scotland),
Pei-Ra Ling, and Charlotte Andersson, and Robert Strijbosch, and Sang Lee, and Anthony Silvestri, and Kathleen M Gura, and Mark Puder, and Bruce R Bistrian
January 1994, Critical reviews in clinical laboratory sciences,
Pei-Ra Ling, and Charlotte Andersson, and Robert Strijbosch, and Sang Lee, and Anthony Silvestri, and Kathleen M Gura, and Mark Puder, and Bruce R Bistrian
July 1984, The American journal of clinical nutrition,
Pei-Ra Ling, and Charlotte Andersson, and Robert Strijbosch, and Sang Lee, and Anthony Silvestri, and Kathleen M Gura, and Mark Puder, and Bruce R Bistrian
January 1983, Annals of surgery,
Copied contents to your clipboard!